Time to read
1 minute
Read so far

Yeast probiotic designed to treat inflammatory bowel disease

Thu, 07/01/2021 - 14:11
Posted in:

Researchers from Brigham and Women's Hospital have developed a designer probiotic - a thoughtfully engineered yeast that can induce multiple effects for treating inflammatory bowel disease (IBD). Previous research by Dr Francisco Quintana, an investigator in the Ann Romney Center for Neurologic Diseases at the Brigham, and colleagues, has helped illuminate the connection between the gut and diseases that affect the brain, suggesting potential applications for engineering probiotics beyond IBD.

Quintana and colleagues developed their probiotic using Saccharomyces cerevisiae, a species of yeast used in winemaking, baking and brewing. Using the gene editing technology CRISPR/Cas9, the researchers introduced genetic elements that could sense inflammation and respond to it by secreting an enzyme that can degrade a key molecule involved in inflammation.

"We've taken yeast - the very yeast that's used to make beer - and we've given it the ability to sense inflammation and secrete an anti-inflammatory molecule," said Quintana, a corresponding author of the paper, ‘Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease’, published in Nature Medicine.

The engineered yeast can secrete different levels of enzyme, depending upon how much of the inflammatory signal is present at a location in the gut. This means that the probiotic can have a highly localized response to inflammation. In mice, the engineered yeast successfully suppressed intestinal inflammation, reduced fibrosis and restored a balanced gut microbiome.

To bring this new therapeutic platform to bear on IBD and other diseases in humans, Quintana and colleagues will need to conduct safety studies. They also plan to further refine and test the engineered yeast to see if they can speed up tissue repair. Beyond IBD, the team plans to investigate the use of engineered probiotics for treating a common side effect of cancer immunotherapy, colitis.

"We want to use the tools of synthetic biology to engineer what can be found in nature," explained Quintana. "By engineering probiotics, our goal is to create more personalized, localized and highly controlled medications for treating diseases of the gut and beyond."